Therapeutic Expertise
We primarily focus on complex specialty markets. Our project experience covers a wide range of therapeutic areas including
- Cardiovascular
- CNS
- Dermatology
- Gastrointestinal
- Hematology
- Immunology
- Infectious Diseases
- Lifestyle Medications
- Metabolic
- Oncology
- Ophthalmology
- Respiratory
- Urology
While our therapeutic experience is diverse, we have built highly focused and specialized expertise in the areas below:
Oncology
- Key focus area of the firm with in-depth specialized expertise
- Proven track record with 700+ projects completed (and growing)
- Global experience (46% US, 16% EU / ROW, 38% global)
- Strategic work across more than 28 tumor types
- Project work with more than 75 products including immunotherapies, biomarker-directed therapeutics, cell and gene therapies, other targeted therapies, and chemotherapeutics
- Unique resources including Oncology Market Entry Strategy and Commercial Models, detailed “Market Maps” for key tumor types, and a “Launch Center of Excellence” with oncology launch tools, plans and roadmaps ready to go
- Significant and growing body of oncology thought leadership
Central Nervous System
- Recently launched CNS Center of Excellence with experienced team members
- In-depth understanding of the unique challenges facing biopharma companies in today’s CNS markets
- 65+ projects completed (and growing) across a diverse range of indications including neurodegenerative diseases, psychiatric disorders, neuro-genetic diseases, neuro-oncology, and pain
- Experience encompassing diverse modalities including small molecules, iRNA, antibodies, cell and gene therapies, digital therapeutics, and others
- Growing body of CNS thought leadership
Rare Diseases
- Key focus area of the firm: A dedicated “Center of Excellence” with specialized expertise
- In-depth understanding of the special development and commercial challenges facing rare disease therapies, as well as a keen “rare disease mindset”
- Service offerings specifically tailored to rare disease needs and challenges
- Substantial experience across 120+ rare disease projects encompassing a wide range of rare disease areas including neurodegenerative diseases, metabolic disorders, hematological disorders, hereditary disorders, and more
- Experience across a diverse range of modalities including antibodies and biologics, iRNA, enzyme replacement therapies, cell and gene therapies, and more
- Significant and growing body of rare disease thought leadership
Digital Therapeutics
- Recently launched digital therapeutics Center of Excellence with specialized team members
- In-depth understanding of the complex and rapidly evolving digital health environment
- Specialized services focused on helping develop, launch, and scale digital health products
- Proprietary tools, including a comprehensive database of prescription digital therapeutics products
- More than 30 projects completed for established biopharma and tech companies, as well as start-ups
- Experience across a diverse range of technologies including mobile apps, AR/VR tech, conversational agents, AI/ML algorithms, wearables, biometric sensors, and virtual care
- Experience across a wide range of therapeutic areas
- Growing body of digital health thought leadership
Contact Us to learn more.
As a founder and managing partner, Ashwin brings 19+ years of life science consulting experience to Blue Matter. Prior to starting Blue Matter, he was Senior VP, Head of Brand Management / Business Development at Campbell Alliance. He is a physician and MBA by training and his specialties include product and portfolio strategy.
As a founder and managing partner of Blue Matter, Emily brings 22 years of life science experience. Prior to Blue Matter, Emily was Senior VP and head of the San Francisco office for Campbell Alliance. Her specialties include product and portfolio strategy and oncology product launches.
As COO and Managing Partner, George brings extensive experience from 20+ years in life science consulting. Previously, George was GM / Head of Europe for Campbell Alliance. His specialties are commercial excellence, organizational design and customer engagement strategy.
Jeron brings 17+ years of life science experience, including more than 12 years in consulting. Previously, Jeron was Corporate Development and Commercial Excellence Lead at Campbell Alliance. His specialties include product, portfolio, and corporate strategy in oncology and diagnostics.
Thomas has 13+ years of experience in life science consulting (bio-pharma / diagnostic). He was formerly VP of Brand Management and Medical Affairs at Campbell Alliance. His specialties include product commercialization and Medical Affairs organization development in oncology and rare diseases.
Pankaj brings an impressive 27+ years of life science experience in industry and consulting to Blue Matter, having held increasingly senior positions at GSK, Bristol-Myers Squibb and Norgine. He was formerly Head of Consulting at IDEA, and he specializes in product, franchise and portfolio strategy, new product planning, and oncology launch readiness. He holds a BSc Pharm from UCL and an MBA from Imperial College London.
With over 12 years in research and consulting for the life sciences, Mary’s primary focus is on product strategy, franchise/portfolio strategy, launch planning, and commercial excellence in oncology and other TAs. She has a PhD in Biology from MIT and also hails from Campbell Alliance.
Kurt is a seasoned expert in market access, with over 24 years of experience. In addition to his extensive experience in life sciences consulting, his background includes several strategic roles across both payers and biopharmaceutical companies (large and small). He earned his undergraduate degree from the University of California, Los Angeles and his JD from Pepperdine University.
Rachael brings an impressive 20 years of experience in the life science industry, which includes 7 years in consulting. Her primary areas of focus are pharmaceutical market access, product launch, and oncology / specialty disease areas. Her background includes 14 years at Biogen, as well as consulting roles at 1798 Consultants and Asselin Consulting Group. She earned an MPH in Epidemiology from Boston University.
Alex has more than 14 years of experience consulting to life science companies. He brings deep expertise in market research and analytics, particularly related to commercial strategy development. Before joining Blue Matter, Alex spent three years at Campbell Alliance and five years at ZS Associates. He earned an MS degree in Management Science from Lehigh University and a degree in Engineering from Lafayette College.
Shankar brings strong scientific and commercial expertise to his consulting work. In his 10+ years in life sciences consulting, he has delivered broadly, including product launch and portfolio strategy across oncology and other therapeutic areas. Shankar earned a BA in Molecular and Cellular Biology from the University of California at Berkeley and a PhD in Biochemistry from MIT.
Matt Durbin brings more than 14 years of life sciences experience to his role at Blue Matter, including 10 years in strategic consulting. Prior to joining Blue Matter, he worked as a consultant for IMS Health. In addition to his consulting experience, Matt spent 3 years performing research at the University of Oxford. He earned a Ph.D. in organic chemistry from the University of Bath.
Isabel has more than 11 years of experience in life science research and strategy consulting. Her work focuses on integrated product and diagnostic strategy, disease area strategy, and launch readiness in oncology. She brings a strong educational background in neuroscience, having earned a Ph.D. in Neuroscience from ETH Zurich. Isabel also has a Certificate of Advanced Studies in Design Thinking.
With more than 16 years in the life sciences, Theo's experience spans from bench to business strategy. For the past 11 years, Theo has provided consulting services to help biopharma companies achieve commercial success in Europe and North America. He leads Blue Matter’s “Pathfinder” business line, which specializes in helping biopharma companies enter and succeed in European markets. Theo earned a Dr. sc. In Physical Chemistry from ETH Zürich and an MBA from IMD Business School.
Yan brings more than 13 years of experience in consulting to life science organizations. Her background includes work with United BioSource Corporation (UBC), Navigant, and Blue Matter. Yan is focused on helping biopharma companies develop pricing, access, and reimbursement strategies in Europe, the US, and other markets around the world. She earned a Ph.D. in cell and molecular biology from the University of Cambridge.
Based in London, Nikos brings more than 16 years of experience providing guidance to pharmaceutical and biotech companies. His background includes consulting work at leading companies including Accenture, IMS Health, InVentiv Health Consulting, and Blue Matter. He earned his M.Eng. degree from UCL (University College London) in Biochemical Engineering with Bioprocess Management.
Jeff brings 15 years of experience in the life sciences. For the past 9 years, he has been consulting in the life science industry. Currently, he leads Blue Matter’s digital health team helping biopharma and start-ups find a path to market for digital innovations. His previous experience includes roles at Navigant and its successor, Guidehouse. His research background includes work in neurodegenerative diseases and neurogenetics. Jeff earned a bachelor’s degree in Cell Biology and Molecular Genetics from the University of Maryland and a Ph.D. in Neurogenetics and Behavior from The Rockefeller University.
Mike has been providing strategic consulting services to pharmaceutical and biotech clients for over 10 years. Prior to joining Blue Matter in 2014, he served healthcare and life science clients at Booz Allen Hamilton. His specialties include product and portfolio strategy in complex / specialty pharmaceutical markets, including significant experience in oncology product launches. Mike earned a B.S. degree in biology from Cornell University.
Joe is a veteran consultant at Blue Matter, having provided strategic guidance to biopharma clients for more than 9 years. While he works on a range of commercial strategy projects, his passion is helping emerging companies shape products, markets, and organizations in preparation for their first launch. Before joining Blue Matter, he earned bachelor’s degrees in Molecular & Cellular Biology and Physics from the University of California, Berkeley.
Bill has been involved with life sciences for 15 years. For more than 7 years, he has provided strategic guidance to biopharma companies. Prior to Blue Matter, Bill worked at ICON plc and Jupiter Life Science Consulting. He brings focused expertise in market access, oncology, rare diseases, infectious diseases, and gene therapy. Bill earned his Ph.D. in Cellular and Molecular Biology from UC Santa Barbara. He also earned a master’s degree in pharmaceutical strategy from the Keck Graduate Institute.
Kelly has been providing strategic guidance to pharmaceutical and biotech companies for the past 8 years. Prior to joining Blue Matter, she served clients while working at Simon Kucher & Partners and Insight Strategy Advisors. Her focus areas are product strategy, market access, and pricing in oncology. She earned a bachelor’s degree in Economics from the University of Rochester and is completing her MBA through Wharton.
Gerdi is a veteran expert in market access strategy and execution, with 20 years of experience in the biopharmaceutical industry. Before joining Blue Matter in 2022, Gerdi served in a range of market access leadership roles covering diverse therapeutic areas and geographies, including Europe, Asia, Middle-East and Latin America. Her background includes positions at Pfizer, Roche, and Galapagos. Gerdi earned a Master of Pharmacy degree from North-West University and an MBA from the University of the Free State in South Africa.
Harris has been a life sciences strategy consultant since 2014. As one of the earliest members of the Blue Matter team, Harris has helped to shape our company's offerings across a number of areas, including commercial product launch, medical affairs strategy, and portfolio lifecycle management. Harris is passionate about crafting insightful narratives from complex business problems, and constantly improving upon the client experience.